The CCN family: a new stimulus package

被引:433
作者
Brigstock, DR
机构
[1] Childrens Res Inst, Ctr Cell & Vasc Biol, Columbus, OH 43205 USA
[2] Ohio State Univ, Dept Surg, Columbus, OH 43212 USA
[3] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43212 USA
[4] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43212 USA
关键词
D O I
10.1677/joe.0.1780169
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The CCN family comprises cysteine-rich 61(CYK61/ CCN1), connective tissue growth factor (CTGF/CCN2), nephroblastoma overexpressed (NOV/CCN3), and Wnt-induced secreted proteins-1 (WISP-1/CCN4), -2(WISP-2/CCN5) and -3 (WISP-3/CCN6). These proteins stimulate mitosis, adhesion, apoptosis, extracellular matrix production, growth arrest and migration of multiple cell types. Many of these activities probably occur through the ability of CCN proteins to bind and activate cell surface integrins. Accumulating evidence supports a role for these factors in endocrine pathways and endocrine-related processes. To illustrate the broad role played by the CCN family in basic and clinical endocrinology, this article highlights the relationship between CCN proteins and hormone action, skeletal growth, placental angiogenesis, IGF-binding proteins and diabetes-induced fibrosis.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 77 条
  • [71] Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C β2 activation and diabetes
    Way, KJ
    Isshiki, K
    Suzuma, K
    Yokota, T
    Zvagelsky, D
    Schoen, FJ
    Sandusky, GE
    Pechous, PA
    Vlahos, CJ
    Wakasaki, H
    King, GL
    [J]. DIABETES, 2002, 51 (09) : 2709 - 2718
  • [72] Cyr61, product of a growth factor-inducible immediate-early gene, regulates chondrogenesis in mouse limb bud mesenchymal cells
    Wong, M
    Kireeva, ML
    Kolesnikova, TV
    Lau, LF
    [J]. DEVELOPMENTAL BIOLOGY, 1997, 192 (02) : 492 - 508
  • [73] Xie D, 2001, CANCER RES, V61, P8917
  • [74] Breast cancer -: Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease
    Xie, D
    Miller, CW
    O'Kelly, J
    Nakachi, K
    Sakashita, A
    Said, JW
    Gornbein, J
    Koeffler, HP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (17) : 14187 - 14194
  • [75] Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis
    Yokoi, H
    Mukoyama, M
    Sugawara, A
    Mori, K
    Nagae, T
    Makino, H
    Suganami, T
    Yahata, K
    Fujinaga, Y
    Tanaka, I
    Nakao, K
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2002, 282 (05) : F933 - F942
  • [76] Role of connective tissue growth factor in profibrotic action of transforming growth factor-β:: A potential target for preventing renal fibrosis
    Yokoi, H
    Sugawara, A
    Mukoyama, M
    Mori, K
    Makino, H
    Suganami, T
    Nagae, T
    Yahata, K
    Fujinaga, Y
    Tanaka, I
    Nakao, K
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : S134 - S138
  • [77] Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation
    Zhang, R
    Averboukh, L
    Zhu, WM
    Zhang, H
    Jo, H
    Dempsey, PJ
    Coffey, RJ
    Pardee, AB
    Liang, P
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (10) : 6131 - 6141